Tech Company Financing Transactions

Meditrina Pharmaceuticals Funding Round

Meditrina Pharmaceuticals, based in San Jose, raised $5 million from Horizon Technology Finance.

Transaction Overview

Announced On
5/9/2019
Transaction Type
Debt
Amount
$5,000,000
Round
Undisclosed
Proceeds Purpose
The company will use the proceeds for further development and accelerate commercial activities of the Aveta system.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1190 Saratoga ave. 180
San Jose, CA 95129
USA
Email Address
Not Recorded
Overview
Meditrina Pharmaceuticals, Inc. identifies and repurposes already marketed therapies and product candidates at advanced stages of development for new indications focused on improving women's health disorders with unmet medical needs.
Profile
Meditrina Pharmaceuticals LinkedIn Company Profile
Social Media
Meditrina Pharmaceuticals Company Twitter Account
Company News
Meditrina Pharmaceuticals News
Facebook
Meditrina Pharmaceuticals on Facebook
YouTube
Meditrina Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Founder
Csaba Truckai
  Csaba Truckai LinkedIn Profile  Csaba Truckai Twitter Account  Csaba Truckai News  Csaba Truckai on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/9/2019: DispatchHealth venture capital transaction
Next: 5/9/2019: Neural Analytics venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary